Issue link: https://www.e-digitaleditions.com/i/1520706
www.biopharminternational.com Partnerships for Outsourcing eBook May 2024 BioPharm International ® 7 Analytics One of the first considerations for choosing the ap- propriate CRO for a project is the expertise of the orga- nization—often reflected by the reputation and longev- ity of the company. With the ever-increasing number of CROs entering the market over the past decade(s), it may seem like a daunting task for a bio/pharma company to find the most suitable and competent organization for its testing needs. Obviously, the longer a CRO has been providing these services with a given track re- cord, the easier it is to assess their competence. Previ- ous customer testimonials and/or references may be a good first start for due diligence. Additionally, access to SMEs in the initial project discussions/phases of the project may allow for a better understanding of the core competencies and capabilities of the CRO, especially when it comes to answering questions and providing consultative advice related to the project. Another major consideration for choosing the appro- priate CRO for a testing project is the focus on regulatory compliance and quality control. This consideration can also be related to the earlier point made about the repu- tation and longevity of a company. A CRO's reputation and longevity may be correlated to the level of quality provided by the organization. An initial first point for a bio/pharma company to consider when considering a CRO for its study is the level of accreditation and FDA history. Such questions as to whether the organization can conduct good laboratory practice or good manufac- turing practice studies should provide a better idea of the level of internal quality control and oversight the CRO provides. If in-vivo testing is required, it is recom- mended that the testing organization have AAALAC International and/or US Department of Agriculture ac- creditation, depending on the species being used. A ded- icated in-house quality assurance (QA) team is always a good sign of the overall quality of the CRO as these departments usually have defined processes that pro- vide extensive oversight of the testing, reporting, and training within the organization. These departments can often arrange an onsite audit by the contracting organization to tour the testing facilities, interview the relevant testing staff members, and review relevant doc- uments, including training records and protocols. Finally, cost is one of the factors that should be con- sidered when choosing a CRO for conducting a preclin- ical study as all companies have budgetary constraints. However, capabilities, quality, and experience should not be sacrificed when cost is considered. While re- searching the prospective location for the outsourced study, it is suggested to get estimations and/or quotes from multiple vendors for comparing the cost and weighing the other key factors appropriately. Conclusion In this article, the author has provided an overview of the reasons why pharmaceutical, biopharmaceutical, and biotechnology companies of all sizes may consider outsourcing their preclinical testing projects, the ad- vantages and disadvantages of this approach, and the critical questions to ask in choosing the appropriate CRO for conducting their outsourced studies. Addi- tionally, time, quality, and cost are critical factors that need to be considered during this outsourcing process to ensure that the project(s) is conducted in an efficient and cost-effective manner. With proper research and interaction with prospective CROs, an appropriate partner should be able to be identified that can suffi- ciently fulfill those critical factors listed above. While this article isn't an exhaustive guide to out- sourcing, it should provide an initial framework for helping an organization identify and conduct their due diligence on a prospective partner for their out- sourced testing project. Please refer to the references provided below for further information and guidance on this topic. References 1. Pacific BioLabs. Learning Center: Outsourcing Strat- egies. pacificbiolabs.com/outsourcing-strategies#benefits (accessed Jan. 29, 2024). 2. Billette de Villemeur, E.; Scannell, J. W.; Versaevel, B. Biopharmaceutical R&D Outsourcing: Short-Term Gain for Long-Term Pain? Drug Discovery Today 2022, 27 (11), 103333. DOI: 10.1016/j.drudis.2022.08.001 3. Gorski, J. 5 Criteria for Choosing a Contract Research Organization. blog.crownbio.com/choosing-best-con- tract-research, April 16, 2019. Q FIGURE 1. Factors to consider when choosing an appropriate contract research organization (CRO) partner are illustrated here. FIGURE IS COURTESY OF THE AUTHOR.